Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000283128 | SCV000346674 | likely benign | Neuroblastoma | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Molecular Genetics Laboratory, |
RCV001173395 | SCV001336483 | benign | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
ARUP Laboratories, |
RCV001764256 | SCV001472798 | benign | not provided | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001764256 | SCV001988715 | benign | not provided | 2021-10-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021339 | SCV002611507 | benign | not specified | 2020-07-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |